Oil Supply Disruption Could Keep Prices Elevated Through 2027 Warns ExxonMobil CEO Samsung Semiconductor Workers Could Receive 400000 Bonus Deal Report South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Disputes Market Update ZBH BUD and VTRS Show Mixed Trends Amid Sector Rotation LeBron James Grip Powder Fetches 2150 at Auction Highlighting Sports Memorabilia Demand Microsofts GitHub Faces Reliability Hurdles in AI Coding Race Amidst Growing Competition REPL Q1 2026 Earnings Narrower Than Expected Loss but Revenue Remains Elusive Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress AWR Q1 2026 Earnings EPS Misses Estimates Slightly as Stock Edges Higher Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress Magyar Bancorp Inc MGYR Q4 2025 Earnings EPS of 040 Achieved Stock Unchanged Brenmiller Energy BNRG Holds Steady at 159 as Stock Consolidates Between Key Levels Braiin Limited BRAI Skyrockets Over 96 Key Levels to Watch Archer Aviation ACHR Rallies 39 as Support Holds Near 604 New Providence Acquisition Corp III Warrants NPACW Edges Higher as Warrants Test Key Resistance Tenon Medical TNON MicroCap Stock Holds Steady Near Key Support Levels SpaceX IPO Speculation Nvidia Earnings Outlook and Bezos AI Bubble Comments Morning Market Roundup AIRO Q4 2025 Earnings EPS Misses Estimates Amid Operational Challenges Southern Company Corporate Units SOMN Hold Near Resistance After Modest Gain OFS Credit Company Inc OCCI Q1 2026 Earnings Massive EPS Miss Highlights Credit Portfolio Headwinds The RealReal Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Vodafone VOD Q4 2025 Earnings EPS Beats Estimates by 408 Amid Modest Market Reaction NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism in Gene Editing Pipeline JOYY Q4 2025 Earnings EPS Misses Estimates Shares Decline 287 CRVS Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Pipeline Progress Douglas Emmett Inc DEI Q1 2026 Earnings Narrowing Losses as EPS Beats Estimates